Page last updated: 2024-08-24

bromfenac and cromolyn sodium

bromfenac has been researched along with cromolyn sodium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Fujishima, H; Fukagawa, K; Fukushima, A; Miyazaki, D; Nakagawa, Y; Okamoto, S; Takano, Y; Tanaka, M; Uchio, E; Yamada, J	1

Trials

1 trial(s) available for bromfenac and cromolyn sodium

Article	Year
Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:3 Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Benzophenones; Bromobenzenes; Conjunctivitis, Allergic; Cromolyn Sodium; Drug Therapy, Combination; Female; Fluorometholone; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Satisfaction; Suspensions	2009

Article

Year

Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:3

Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Asthmatic Agents; Benzophenones; Bromobenzenes; Conjunctivitis, Allergic; Cromolyn Sodium; Drug Therapy, Combination; Female; Fluorometholone; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Satisfaction; Suspensions

2009

Other Studies

1 other study(ies) available for bromfenac and cromolyn sodium

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011